Nautilus Biotechnology, Inc. (NAUT)

2.82 -0.07 (-2.42%) USD  |  NASDAQ  |  Feb 20, 16:00
2.83 +0.01 (+0.35%) After-Hours: 20:00
More

Nautilus Biotechnology EPS Diluted (Quarterly YoY Growth)

EPS Diluted (Quarterly YoY Growth) Chart

View EPS Diluted (Quarterly YoY Growth) for NAUT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly YoY Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years

View EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly YoY Growth) Benchmarks

View EPS Diluted (Quarterly YoY Growth) Benchmarks
Start Trial
Nephros, Inc. Upgrade
Prelude Therapeutics, Inc. Upgrade
Pyxis Oncology, Inc. Upgrade
ProKidney Corp. Upgrade
Neumora Therapeutics, Inc. Upgrade